Short Interest in Biocorrx Inc. (OTCMKTS:BICX) Drops By 68.8%

Biocorrx Inc. (OTCMKTS:BICX) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 543 shares, a decrease of 68.8% from the July 15th total of 1,741 shares. Based on an average daily trading volume, of 15,973 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are sold short.

Biocorrx Trading Down 45.7%

BICX stock opened at $0.15 on Friday. The business’s 50-day moving average price is $0.32 and its two-hundred day moving average price is $0.35. The firm has a market cap of $4.52 million, a PE ratio of -1.27 and a beta of 0.19. Biocorrx has a 1-year low of $0.15 and a 1-year high of $1.28.

Biocorrx (OTCMKTS:BICX) last posted its earnings results on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The business had revenue of $0.09 million during the quarter, compared to analyst estimates of $0.24 million.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.